Abstract:ABSTRACT Mammalian target of rapamycin (mTOR) is a key regulator of metabolism in the mammalian cell. Here, we show the essential role for mTOR signaling in the immune response to bacterial infection. Inhibition of mTOR during infection with Staphylococcus aureus revealed that mTOR signaling is required for bactericidal free radical production by phagocytes. Mechanistically, mTOR supported glucose transporter GLUT1 expression, potentially through hypoxia-inducible factor 1α, upon phagocyte activation. Cytokine and chemokine signaling, inducible nitric oxide synthase, and p65 nuclear translocation were present at similar levels during mTOR suppression, suggesting an NF-κB-independent role for mTOR signaling in the immune response during bacterial infection. We propose that mTOR signaling primarily mediates the metabolic requirements necessary for phagocyte bactericidal free radical production. This study has important implications for the metabolic requirements of innate immune cells during bacterial infection as well as the clinical use of mTOR inhibitors. IMPORTANCE Sirolimus, everolimus, temsirolimus, and similar are a class of pharmaceutics commonly used in the clinical treatment of cancer and the anti-rejection of transplanted organs. Each of these agents suppresses the activity of the mammalian target of rapamycin (mTOR), a master regulator of metabolism in human cells. Activation of mTOR is also involved in the immune response to bacterial infection, and treatments that inhibit mTOR are associated with increased susceptibility to bacterial infections in the skin and soft tissue. Infections caused by Staphylococcus aureus are among the most common and severe. Our study shows that this susceptibility to S. aureus infection during mTOR suppression is due to an impaired function of phagocytic immune cells responsible for controlling bacterial infections. Specifically, we observed that mTOR activity is required for phagocytes to produce antimicrobial free radicals. These results have important implications for immune responses during clinical treatments and in disease states where mTOR is suppressed.

Critical roles of mTORC1 signaling and metabolic reprogramming for M-CSF–mediated myelopoiesis

The MTOR signaling pathway regulates macrophage differentiation from mouse myeloid progenitors by inhibiting autophagy

mTORC1 Signaling Regulates Proinflammatory Macrophage Function and Metabolism

mTORC2 orchestrates monocytic and granulocytic lineage commitment by an ATF5-mediated pathway

Hippo Kinase MST1-Mediated Cell Metabolism Reprograms the Homeostasis and Differentiation of Granulocyte Progenitor Cells.

mTORC1 and mTORC2 as regulators of cell metabolism in immunity

Mtor-Mediated Glycolysis Contributes to the Enhanced Suppressive Function of Murine Tumor-Infiltrating Monocytic Myeloid-Derived Suppressor Cells

mTOR masters monocytic myeloid-derived suppressor cells in mice with allografts or tumors

mTOR Signaling as a Regulator of Hematopoietic Stem Cell Fate

Activating transcription factor 4-dependent hsa-miR-663a transcription mediates mTORC1/p70S6K1 signaling underleucine deprivation

Activating transcription factor 4-dependent hsa-miR-663a transcription mediates mTORC1/p70S6K1 signaling underleucine deprivation.

Mtor Signaling Disruption from Myeloid-Derived Suppressive Cells Protects Against Immune-Mediated Hepatic Injury Through the HIF1α-dependent Glycolytic Pathway.

Metabolic Signaling Directs the Reciprocal Lineage Decisions of Αβ and Γδ T Cells

Proinflammatory Signal Suppresses Proliferation and Shifts Macrophage Metabolism from Myc-dependent to HIF1α-dependent

Mitochondrial pyruvate metabolism and glutaminolysis toggle steady-state and emergency myelopoiesis

Mtor and Metabolic Regulation of Conventional and Regulatory T Cells

Mouse Gene Targeting Reveals an Essential Role of Mtor in Hematopoietic Stem Cell Engraftment and Hematopoiesis

Rheb1-mTORC1 Maintains Macrophage Differentiation and Phagocytosis in Mice.

Integrated transcriptomic and metabolomic analysis reveals the metabolic programming of GM-CSF- and M-CSF- differentiated mouse macrophages

mTOR signaling is required for phagocyte free radical production, GLUT1 expression, and control of Staphylococcus aureus infection

Tumor Microenvironment Modulates Immunological Outcomes of Myeloid Cells with mTORC1 Disruption